Verner R, Beraldi F, Tzadok M, Fahoum F, Tahry RE, Gelfand MA, Morris G, Motamedi GK, Zafar M, Sen A, Boffini M, Gordon C, Dibué M; CORE-VNS Study Group. CORE-VNS: Dosing and titration of VNS therapy in contemporary clinical practice , Epilepsy Behav Rep, 33: 2026,100847
Potnis O, Biondo G, Sukonik R, Grzeskowiak C, Cutter G, Altalib H, Kuzniecky R, Lowenstein D, French J; HEP2 Investigators. Seizure Frequency Trends Over Time in Treatment-Resistant Focal Epilepsy , JAMA Neurol, 82: 2025,1257-1264
Barnard SN, Chen Z, Holmes M, Kanner AM, Hegde M, Kuzniecky R, Lowenstein D, French JA; Human Epilepsy Project (1) Investigators. Treatment Response to Antiseizure Medications in People With Newly Diagnosed Focal Epilepsy , JAMA Neurol, 82: 2025,1022-1030
Xie K, Korzun J, Zhou DJ, Chang E, Ghosn NJ, Lavelle S, Oganisian A, Acton EK, Gelfand MA, Roth D, Litt B, Ellis CA. Comparative effectiveness of anti-seizure medications in emulated trials using medical informatics , Brain, 148: 2025,4288-4298
Xu Z, Scheid BH, Conrad EC, Davis KA, Ganguly T, Gelfand MA, Gugger JJ, Jiang X, LaRocque JJ, Ojemann WKS, Sinha SR, Waldman GJ, Wagenaar J, Sinha N, Litt B. Annotating neurophysiologic data at scale with optimized human input , J Neural Eng, 22: 2025,046003
Dave H, Sperling MR, Altalib HH, Henninger H, Porter RJ, Gelfand M, Dongre P, Elmoufti S, Martin MS, Schulz AL, French JA. Brivaracetam effectiveness and patient-reported outcomes in clinical practice: Data from a 12-month prospective, observational study in the United States , Epilepsy Behav, 173: 2025,110565
Alkofer M, Yang C, Ganglberger W, Beal J, Hegde M, Kang JY, Yoo JY, Gelfand MA, Thio LL, Kutluay E, Campbell Z, Schmitt S, Gleichgerrcht E, Waterhouse E, Lopez MR, Eisenschenk S, Galanti M, Singh RK, Wills KE, Meulenbrugge EJ, Dlugos D, Dean B, Halford JJ, Goldenholz D, Jing J, Thomas R, Westover MB. Automated detection of interictal epileptiform discharges with few electroencephalographic channels , Epilepsia, 66: 2025,e114-20
French JA, Porter RJ, Perucca E, Brodie MJ, Rogawski MA, Harden C, Qian J, Rosenblut CL, Kenney C, Beatch GN; X‐TOLE Study Group. Interim analysis of the long-term efficacy and safety of azetukalner in an ongoing open-label extension study following a phase 2b clinical trial (X-TOLE) in adults with focal epilepsy , Epilepsia Open: 2025
Barnard SN, Chen Z, Kanner AM, Holmes MG, Klein P, Abou-Khalil BW, Gidal BE, French J, Perucca P; Human Epilepsy Project. The Adverse Effects of Commonly Prescribed Antiseizure Medications in Adults With Newly Diagnosed Focal Epilepsy , Neurology, 103: 2024,e209821
Acton EK, Hennessy S, Gelfand MA, Leonard CE, Bilker WB, Shu D, Willis AW, Kasner SE. Direct-Acting Oral Anticoagulants and Antiseizure Medications for Atrial Fibrillation and Epilepsy and Risk of Thromboembolic Events , JAMA Neurol, 81: 2024,835-844
